📈 TB-500 Protocol

 

Educational purposes only — not medical advice.
TB-500 is not FDA-approved and does not have official human dosing guidelines.

⸻

Lesson 1: What Is TB-500?

TB-500 is a synthetic peptide related to Thymosin Beta-4, a naturally occurring peptide studied for tissue repair, cell migration, and wound-healing pathways.

Researchers study TB-500 for:

✅ Soft tissue repair signaling
✅ Muscle, tendon, and ligament research
✅ Mobility and recovery research
✅ Wound-healing pathways
✅ Inflammation-related research

Thymosin Beta-4 has been studied in wound healing, tissue regeneration, and anti-inflammatory models.  

⸻

Lesson 2: What Makes TB-500 Different?

Simple version:

BPC-157 is often discussed for localized repair and gut-related research.
TB-500 is often discussed for broader, body-wide repair signaling and mobility research.

TB-500 is commonly paired with BPC-157

⸻

Lesson 3: Common Protocol

🧗♂️ Phase 1: The Loading Phase (Weeks 1–4 or 1–6)

The goal here is to rapidly build up systemic levels of the peptide to jumpstart angiogenesis (new blood vessel growth) and tissue remodeling.

  • 📏 Standard Loading Dose: 4 mg to 10 mg total per week.

  • 🔁 Frequency: This weekly total is always split into two separate injections (e.g., 2.5 mg to 5 mg administered every 3.5 days, such as Mondays and Thursdays) to maintain stable serum levels.

🔧 Phase 2: The Maintenance Phase (Weeks 5–12)

Once the tissue signaling environment is established, the frequency drops to keep the recovery pathways active without overloading receptors.

  • 📏 Standard Maintenance Dose: 2 mg to 5 mg total per week.

  • 🔁 Frequency: Administered as a single injection once per week (or split into two smaller doses if dealing with severe, chronic structural damage).

🛑 Phase 3: The Taper & Break (Month 3+)

  • ⏳ The Protocol Break: After a 6 to 12-week continuous cycle, a mandatory rest period of 4 to 8 weeks is standard practice. This break prevents receptor accommodation and gives the body time to consolidate the structural tissue remodeling initiated by the peptide.

⸻

Lesson 4: When To Increase

Researchers may consider increasing only when:

✅ The starting amount is tolerated
✅ No swelling, irritation, dizziness, or unusual symptoms occur
✅ The research goal is not being met
✅ No other new compounds were added at the same time
✅ Recovery, movement, sleep, and nutrition are already consistent

A simple rule:

Do not increase just because recovery is slow. Tissue repair takes time.

⸻

Lesson 5: When To Stop Increasing

Stop increasing when:

* Desired research response is reached
* No added benefit is noticed
* Side effects appear
* Unusual swelling or inflammation occurs
* The research cycle has already run long enough
* Multiple compounds are being stacked and results become unclear

The goal is the lowest useful amount for the shortest reasonable cycle, not staying on indefinitely.

⸻

Lesson 6: Common Side Effects To Watch For

Because TB-500 lacks large human safety trials, the full side-effect profile is not well established.

Researchers commonly watch for:

* Injection-site irritation
* Redness or swelling
* Headache
* Fatigue
* Dizziness
* Nausea
* Water retention
* Flu-like feeling
* Allergic-type reactions.  

⸻

Lesson 7: Important Safety Notes

Use extra caution with TB-500 research involving:

* Pregnancy or breastfeeding
* Cancer history or active tumors
* Autoimmune disease
* Blood clotting issues
* Recent surgery
* Active infection
* Competitive athletes

TB-500 and Thymosin Beta-4 derivatives are listed by WADA as prohibited substances in sport.  

Seek medical help for chest pain, trouble breathing, severe swelling, allergic reaction, fever, worsening infection, or severe abdominal pain.

⸻

Prime Labs Key Takeaway

TB-500 is best understood as a broad tissue-repair research peptide, not a proven healing medication.

Start low, keep the protocol simple, avoid stacking too many variables, and stop increasing once the lowest useful range is reached.

🌐 PrimeLabZone.com — Free Education Library